Related Experiment Video
Updated: May 30, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Mechanisms of RNA interference in the HIV-1-host cell interplay
María Sánchez-Del Cojo1, María Rosa López-Huertas, Elena Mateos
1AIDS Immunopathology Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Abstract:
The RNA interference pathway is a mechanism to regulate gene expression that acts in mammalian antiviral immunity as a complement of interferon- and cytokine-based innate immunity. RNA interference has been proposed as an ancient mechanism against viruses since several components of this system show an effect against viral replication. In fact, protein effectors of this pathway, as well as synthesized microRNA, act against HIV-1, exerting a partial control over HIV-1 latency and replication. Conversely, HIV-1 may counteract this antiviral cell response through two major lines of attack: first, its main regulator Tat suppresses the cellular RNA interference pathway; and second, the virus synthesizes viral microRNA that alter specific cellular functions to enhance HIV-1 replication. As a result of this complex interaction, the microRNA profile in an HIV-1-infected cell is deeply modified. One key application of all this knowledge is the development of pharmacological treatment since microRNA expression can be manipulated and artificial small interference RNA can be delivered into the infected cell to inhibit viral replication. This strategy, combined with current antiretroviral therapy, could be valuable in controlling HIV-1 replication in infected cells.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Retrovirus Life Cycles
Experimental RNAi

